Abstract:The title of this contribution was adopted from one of the many obituaries that were published after the death of Norman Breslow on December 9, 2015, aged 74 years. It is remarkable that not only his home institution, the University of Washington, the International Biometric Society and other statistical societies, but also The Lancet as one of the most prominent, general medical journals published a one-page obituary especially highlighting his contributions to medical research (Watts, 2016). Most biostatisticians will know at least some of his groundbreaking contributions to survival analysis, the most popular of which is his investigation on the statistical properties of the Kaplan–Meier estimator for censored survival data that he published jointly with John Crowley (Breslow and Crowley, 1974). This publication is most likely the major reason, that the Kaplan–Meier estimator was rediscovered for medical statistics and became the accepted standard method of survival analysis since then. There were, however, further contributions of similar importance to this field and closely connected with his name: Sequential analysis of survival data (Breslow, 1969), a K-sample test (“the Breslow test”) for censored survival data (Breslow, 1970), an estimator for the baseline cumulative hazard (“the Breslow estimator”) in a Cox proportional hazard model (Breslow, 1972) and the first modern treatment of survival data in the presence of competing risks (Prentice et al., 1978). Colleagues working in the field of epidemiology will probably know two other publications even better: the IARC monographs on “Statistical Methods in Cancer Research” that he worked out together with Nick Day during his many visits at the International Agency for Research on Cancer (IARC) in Lyon, France. Volume I on “The Analysis of Case-Control Studies” (Breslow and Day, 1980) and Volume II on “The Design and Analysis of Cohort Studies” (Breslow and Day, 1987) served for decades and still serve as the standard textbooks for researchers in the field of cancer epidemiology. I met Norman Breslow for the first time in the early 1980s as I worked at the Institute of Medical Statistics of the Heidelberg University. My project was focused on statistical modeling for clinical trials in breast cancer and was part of the Collaborative Research Center “Stochastic Mathematical Models.” Norman spent a year in Heidelberg at the German Cancer Research Center as a fellow of the Alexandervon-Humboldt Foundation. During this time, I remember one of his seminars on “Estimation of the odds ratio” promoting the use of the Mantel–Haenszel estimator in sparse data situations (Breslow, 1981), a topic that he further developed jointly with Sander Greenland and Jamie Robins (Robins et al., 1986). I was, however, even more impressed by another lecture of Norman on goals and achievements of the National Wilms Tumor Study where he was the responsible statistician. As a member and an integral part of the national study group for more than 30 years, he published about 94 papers (37 of which as first or last author) devoted to the etiology, diagnosis, treatment, and long-term prognosis of a rare pediatric kidney tumor showing his in-depth subject-matter knowledge and dedication to a longlasting cooperation with his clinical colleagues. During the time he spent in Heidelberg, I had regular

A11216 Baroreflex Activation Therapy in Combination with Slow Breathing and External Stimulation of Carotid Sinus in the Treatment of Hypertension

Carotid Baroreceptor Stimulation: A Potential Solution for Resistant Hypertension

[Effect of Astragalus Membranaceus on Baroreflex Sensitivity in Spontaneously Hypertensive Rats].

Intradermal variant of nodular ‘fasciitis’

[Nursing and its changes in the preparation of psychiatric patients for non-institutional care in the residential home ward at Oulunsuu Hospital in 1977-1988].

Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis

Magnetic stimulation of carotid sinus as a treatment for hypertension.

Monitoring of the regulatory ability and regulatory state of the autonomic nervous system and its application to the management of hypertensive patients: a study protocol for randomised controlled trials

External counterpulsation stimulation combined with acupuncture for vascular endothelial function in patients with hypertension: A randomized pilot trial

Carotid Baroreceptor Stimulation Ameliorates Pulmonary Arterial Remodeling in Rats With Hypoxia-Induced Pulmonary Hypertension

Immunomodulation of helicobacter infection.

EFFECT OF AN ELECTRO-STIMULATOR DEVICE ON THE AVERAGE 24-HOUR BLOOD PRESSURE IN PATIENTS WITH MILD AND MODERATE HYPERTENSION

Hemodynamic Responses to Magnetic Stimulation of Carotid Sinus in Normotensive Rabbits

Effectiveness of An Impedance Cardiography Guided Treatment Strategy to Improve Blood Pressure Control in A Real-World Setting: Results from A Pilot Pragmatic Clinical Trial

Chronic Remote Ischemic Conditioning on Mild Hypertension in the Absence of Antihypertensive Medication: a Multicenter, Randomized, Double-Blind, Proof-of-Concept Clinical Trial

Carotid Baroreceptor Stimulation Improves Pulmonary Arterial Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Smart phone-based transcutaneous electrical acupoint stimulation as adjunctive therapy for hypertension (STAT-H trial): protocol for a cluster randomised controlled trial

Low-Level Tragus Stimulation Attenuates Blood Pressure in Young Individuals With Hypertension: Results From a Small-Scale Single-Blind Controlled Randomized Clinical Trial

Norman Edward Breslow–Key figure in the foundation of modern biostatistics

Real-time closed-loop brainstem stimulation modality for enhancing temporal blood pressure reduction

Low-intensity focused ultrasound combined with microbubbles for non-invasive downregulation of rabbit carotid body activity in the treatment of hypertension